维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Yeo TS"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Serodiagnosis of human sparganosis by a monoclonal antibody-based competition ELISA显示文摘	Yeo IS Yong TS Im K	1994	Yonsei Med J1994，35，1：	1
2	An alternative early knee flexion regimen of continuous passive motion for total knee arthroplasty显示文摘	Ng TS Yeo SJ	1999	Physiotherapy Singapore1999，2，：	1
3	A novel lacunarity estimation method applied to SAR image segmentation显示文摘	Du Gan Yeo TS	2000	IEEE Transaction on Geoscience and Remote Sensing2000，40，12：	1
4	A randomized phase Ⅲ study of doxorubicin versus eisplatin/interferon alpha-2b/doxorubicin/flu- omuracil(PIAF) combination chemotherapy for unreseetable hep- atocellular carcinoma 显示文摘	Yeo W Mok TS Zee B	2005	J Natl Cancer Inst2005，97，20：	1
5	A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil(PIAF)combination chemotherapy for unresectable hepatocellular carcinoma显示文摘	Yeo W Mok TS Zee B	2005	J Natl Cancer Inst2005，97，20：	1
6	Delineating biological pathways unique to embryonic stem cel-derived insulin-producing cel lines from their noninsulin-producing progenitor cel lines显示文摘	Chen TS Tan SS Yeo RW		0，，08：	1
7	Brain metastasis responding to gefitinib alone显示文摘	Poon AN Ho SS Yeo W Mok TS	2004	Oncology2004，67，2：	1
8	A novel muhifractal estimation method and its application to remote image segmentation显示文摘	Du G Yeo TS	2002	IEEE Trans on GEOSCI REMOTE2002，40，4：	1
9	Serodiagnosis of human sparganosis by a monoclonal antibody-based competition ELISA显示文摘	Yeo IS Yong TS Im K	1994	Yonsei Med J1994，35，1：	1
10	A randomized phase Ⅲ study of doxorubicin versus cisplatin/interferon alpha-2b/ doxombicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma显示文摘	Yeo W Mok TS Zee B	2005	J Natl Cancer lnst2005，97，20：	1
11	An intensive surveillance programdetected a high incidence of hepatocellular carcinoma among hepatitisB virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results显示文摘	Mok TS Yeo W Yu S	2005	J Clin Oncol2005，23，31：	1
12	A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity显示文摘	Mok TS Yeo W Johnson PJ Hui P	2007	Ann Oncol2007，18，4：	1
13	A randomized phase Ⅲ study of doxorubicin versus cisplatin/intefferon alpha-2b/doxorubicin/fluoivuracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma显示文摘	Yeo W Mok TS Zee B	2005	J Natl Cancer Inst2005，97，20：	1
14	Serodiagnosis of human sparganosis by a monoelonal antibody based competition ELISA显示文摘	Yeo IS Yong TS Im K	1994	Yonsei Med J1994，35，1：	1
15	Arandomized phase Ⅱ study of doxorubicin versus cisplatin/interfeon alpha 2b/doxorubicin/fluorouracil(PLAF)combination chemotherapy for unresectable hepatocellular carcinoma显示文摘	Mok TS Zee B	2005	J Natl Cancer Inst2005，97，20：	1
16	Wave Mode and Path Char- acteristics in a Four-Layered Anisotropic Forest Environ- ment显示文摘	Li LW Lee CK Yeo TS	2004	IEEE Transactions on Antennas and Propagation2004，52，9：	1
17	A randomized phase Ⅲ study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma显示文摘	Yeo W Mok TS Zee B	2005	J Natl Cancer Inst2005，97，：	1
18	An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results显示文摘	Mok TS Yeo W Yu S	2005	J Clin Oncol2005，23，31：	1
19	A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/ fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellu\|ar carcinoma 显示文摘	YEO W MOK TS ZEE B	2005	J Natl Cancer lnst2005，97，：	1
20	A novel multifractal estimation method and its application to remote image seglnentation显示文摘	DU G YEO TS	2002	IEEE Transactions on Geoscience Remote Sensing2002，40，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示